IP Library Granted Patent US 8,309,709
Granted Patent B2
US 8,309,709 · App. 11/913,236 · Granted Nov 13, 2012

Method of preparing a separation matrix

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,309,709
App. No.
11/913,236
Granted
Nov 13, 2012
Kind
B2
Abstract

The present invention relates to a method of preparing an insoluble separation matrix, which method comprises salt-treatment of a polysaccharide gel followed by cross-linking of the polysaccharide polymers. In one embodiment, the method comprises providing an aqueous solution of a gelatable native polysaccharide; lowering the temperature of the polysaccharide solution to a value below its gelling point; salt-treatment by adding at least one salt to the resulting polysaccharide; and cross-linking the salt-treated polysaccharide. The polysaccharide may be prepared e.g. into particles, membranes or monoliths.

Claims (25)

1. A method of preparing a separation matrix comprising:

(a) providing an aqueous suspension of particles comprised of gelled native polysaccharide;

(b) salt-treatment of the suspended particles by adding at least one salt; and

(c) cross-linking of the salt-treated particles;

wherein the salt(s) are added up to a salt concentration in the suspension in the range of 0.5 to 1.3 M, and wherein the temperature during the salt-treatment is in the range of 94-98° C.

2. The method of claim 1 , wherein the polysaccharide is agarose.

3. The method of claim 1 , wherein the anion of the salt added in step (b) is a sulphate.

4. The method of claim 1 , wherein the cation of the salt is selected from the group consisting of Mg; Na; K; Li; and Cu.

5. The method of claim 4 , wherein the cation of the salt is selected from the group consisting of Mg and Na.

6. The method of claim 1 , wherein the salt is MgSO 4 .

7. The method of claim 1 , wherein the temperature during the salt treatment is about 96° C.

8. The method of claim 1 , wherein the polysaccharide particles of step (a) have been prepared by emulsification in an organic solvent.

9. The method of claim 8 , wherein the particles are washed after the emulsification.

10. The method of claim 1 , additionally comprising a step of attaching chromatography ligands to hydroxyl groups of the gelled polysaccharide.

11. A cross-linked polysaccharide separation matrix produced by the method of claim 1 .

12. The matrix of claim 11 , wherein the available pore volume corresponds to a K av value for a dextran of 110 kD of at least 0.5.

13. A chromatography column comprising the separation matrix of claim 11 .

14. A method of preparing a separation matrix comprising:

(i) providing an aqueous solution of a gelatable native polysaccharide;

(ii) lowering the temperature of the polysaccharide solution to a value below its gelling point;

(iii) salt-treatment by adding at least one salt selected from sulphate or phosphate salt to the polysaccharide resulting from (ii); and

(iv) cross-linking the salt-treated polysaccharide;

wherein the salt(s) are added up to a salt concentration in the range of 0.5 to 1.3 M, and wherein the temperature during the salt-treatment is in the range of 94-98° C.

15. A cross-linked polysaccharide separation matrix produced by the method of claim 14 .

16. The matrix of claim 15 , which is a membrane or a monolith.

Assignments (3)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2007
From: BERG, HANS; BRANNHOLM, MARIA; BUCKLEY, DAVID; BUSSON, PHILIPPE; HAGVALL, ANDERS; HOLMGREN, EVA; IHRE, HENRIK; LARSSON, ANDERS; LINDSTROM, DAG
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 020044/0086 →